Observational studyFrontiers in cellular and infection microbiology2026
Reduced gut microbial diversity characterized by decreased
Observational study in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vasovagal syncope (VVS) represents the most prevalent form of orthostatic intolerance in children and is characterized by recurrent fainting episodes that substantially impair quality of life and psychosomatic well-being. The pathogenesis of VVS is primarily associated with dysregulation of the autonomic nervous system. Emerging evidence suggests that the gut microbiota, a complex microbial community residing in the human intestine, plays a pivotal pathological role in various autonomic nervous system related disorders. However, data on the gut microbiota profile in pediatric VVS remain limited. The present study therefore aims to characterize gut microbiota changes in children with VVS and its subtypes, providing novel insights into the underlying mechanisms and potential therapeutic strategies. Method: Fecal samples were obtained from 40 children diagnosed with VVS, comprising 20 with the vasodepressor subtype, 8 with the cardioinhibitory subtype, and 12 with the mixed subtype, as well as from 60 age-matched healthy controls. Microbial community composition was assessed through 16S rRNA gene sequencing. Alpha and beta diversity analyses were conducted to evaluate differences between the VVS and HC groups, as well as among the different VVS subtypes. Then, the bacterial flora with significant differences was identified based on microbial relative abundance data using the Wilcoxon rank-sum test, ANCOM-BC2, and LEfSe analyses. Results: Compared with HCs, children with VVS exhibited reduced alpha diversity, reflected by lower Simpson and Shannon indices. Beta diversity analysis indicated a modest shift in community structure based on Bray-Curtis and weighted UniFrac distances, accompanied by increased within-group dispersion in VVS. No significant differences were detected in dominant phyla. At the genus level, among the predominant taxa, ANCOM-BC2 identified decreased Conclusion: Our findings provide evidence of gut microbiota alterations in children with VVS and suggest that reduced microbial diversity, particularly the decreased abundance of the key genera
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.